Page last updated: 2024-12-11

thermozymocidin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thermozymocidin: a serine palmitoyltransferase inhibitor; FTY720 is an analog [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6438394
CHEMBL ID55076
CHEBI ID582124
SCHEMBL ID6542261
SCHEMBL ID8499386
MeSH IDM0042446

Synonyms (53)

Synonym
myriocin ,
(2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid
myriocin from mycelia sterilia, >=98% (hplc), powder
isp-1
NCGC00163597-01
thermozymocidin
6-eicosenoic acid, 2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-, (2s-(2r*,3s*,4s*,6e))-
NCGC00163597-02
35891-70-4
isp-i
CHEMBL55076
antibiotic isp-i
CHEBI:582124 ,
(2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid
(e,2s,3r,4r)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid
NCGC00163597-03
C19914
dtxsid9046360 ,
tox21_112062
tox21_113400
cas-35891-70-4
dtxcid7026360
unii-yrm4e8r9st
yrm4e8r9st ,
myriocin from mycelia sterilia
(+)-myriocin
gtpl6664
6-eicosenoic acid, 2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-, (2s,3r,4r,6e)
myriocin [mi]
CCG-208239
NCGC00163597-04
tox21_112062_1
SCHEMBL6542261
SCHEMBL8499386
HMS3649I03
LMFA01060203
myriocin (isp-1)
SR-05000002333-2
sr-05000002333
AKOS030568046
myriocin,mycella sterilia
(2s,3r,4r,e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid
myriocin, mycelia sterilia - cas 35891-70-4
SR-05000002333-3
Q6948247
HY-N6798
CS-W020835
'(2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid'
VRP ,
thermozymocidin;(2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid
F85634
bdbm50461646
myriocin; isp-1

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Unfortunately these molecules cause a gastric enteropathy after chronic dosing in rats."( Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase.
Adams, LA; Brozinick, JT; Estridge, T; Genin, MJ; Gonzalez Valcarcel, IC; Hawkins, E; Holloway, WG; Lamar, J; Mosior, M; Reynolds, VL; Seng, T; Weidner, J; Weller, J; Yurek, D, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
immunosuppressive agentAn agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitorAn EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor that interferes with the action of serine palmitoyltransferase (EC 2.3.1.50).
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
sphingoidSphinganine, its homologs and stereoisomers, and the hydroxy and unsaturated derivatives of these compounds.
alpha-amino fatty acidA fatty acid with an amino substituent at position C-2.
non-proteinogenic alpha-amino acidAny alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
hydroxy monocarboxylic acidAny monocarboxylic acid which also contains a separate (alcoholic or phenolic) hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency15.81140.140911.194039.8107AID2451
GALC proteinHomo sapiens (human)Potency0.316228.183828.183828.1838AID1159614
TDP1 proteinHomo sapiens (human)Potency0.05680.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency11.88560.000714.592883.7951AID1259369; AID1259392
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency9.19620.003041.611522,387.1992AID1159555
estrogen nuclear receptor alphaHomo sapiens (human)Potency5.35380.000229.305416,493.5996AID743075
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency0.00230.005612.367736.1254AID624032
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serine palmitoyltransferase 2Homo sapiens (human)IC50 (µMol)0.00010.00010.00010.0001AID1392237
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serine palmitoyltransferase 1Homo sapiens (human)EC50 (µMol)0.04950.04950.04950.0495AID1635338
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (9)

Processvia Protein(s)Taxonomy
sphingolipid biosynthetic processSerine palmitoyltransferase 1Homo sapiens (human)
ceramide biosynthetic processSerine palmitoyltransferase 1Homo sapiens (human)
positive regulation of lipophagySerine palmitoyltransferase 1Homo sapiens (human)
sphingolipid metabolic processSerine palmitoyltransferase 1Homo sapiens (human)
sphingomyelin biosynthetic processSerine palmitoyltransferase 1Homo sapiens (human)
sphingolipid biosynthetic processSerine palmitoyltransferase 1Homo sapiens (human)
sphinganine biosynthetic processSerine palmitoyltransferase 1Homo sapiens (human)
sphingosine biosynthetic processSerine palmitoyltransferase 1Homo sapiens (human)
regulation of fat cell apoptotic processSerine palmitoyltransferase 1Homo sapiens (human)
ceramide biosynthetic processSerine palmitoyltransferase 1Homo sapiens (human)
sphingolipid biosynthetic processSerine palmitoyltransferase 2Homo sapiens (human)
ceramide biosynthetic processSerine palmitoyltransferase 2Homo sapiens (human)
positive regulation of lipophagySerine palmitoyltransferase 2Homo sapiens (human)
sphingomyelin biosynthetic processSerine palmitoyltransferase 2Homo sapiens (human)
sphingolipid biosynthetic processSerine palmitoyltransferase 2Homo sapiens (human)
sphinganine biosynthetic processSerine palmitoyltransferase 2Homo sapiens (human)
sphingosine biosynthetic processSerine palmitoyltransferase 2Homo sapiens (human)
adipose tissue developmentSerine palmitoyltransferase 2Homo sapiens (human)
ceramide biosynthetic processSerine palmitoyltransferase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
serine C-palmitoyltransferase activitySerine palmitoyltransferase 1Homo sapiens (human)
serine C-palmitoyltransferase activitySerine palmitoyltransferase 1Homo sapiens (human)
protein bindingSerine palmitoyltransferase 1Homo sapiens (human)
pyridoxal phosphate bindingSerine palmitoyltransferase 1Homo sapiens (human)
serine C-palmitoyltransferase activitySerine palmitoyltransferase 2Homo sapiens (human)
serine C-palmitoyltransferase activitySerine palmitoyltransferase 2Homo sapiens (human)
pyridoxal phosphate bindingSerine palmitoyltransferase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
endoplasmic reticulumSerine palmitoyltransferase 1Homo sapiens (human)
endoplasmic reticulum membraneSerine palmitoyltransferase 1Homo sapiens (human)
serine C-palmitoyltransferase complexSerine palmitoyltransferase 1Homo sapiens (human)
SPOTS complexSerine palmitoyltransferase 1Homo sapiens (human)
endoplasmic reticulumSerine palmitoyltransferase 1Homo sapiens (human)
endoplasmic reticulum membraneSerine palmitoyltransferase 2Homo sapiens (human)
serine C-palmitoyltransferase complexSerine palmitoyltransferase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (84)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1635362Reduction in plasma C18:0 ceramide level in diet-induced obese C57BL6 mouse at 0.5 mg/kg administered daily through oral gavage for 28 days measured 2 hrs post last dose relative to lean control2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase.
AID507284Inhibition of serine palmitoyltransferase in human Jurkat JA16 cells assessed as lateral diffusion of the outer membrane leaflet-linked GFP-AKt nanodomain at 25 uM after 14 to 18 hrs by fluorescence correlation spectroscopy2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID507280Inhibition of squalene synthase in human Jurkat JA16 cells assessed as cholesterol level at 25 uM after 14 to 18 hrs by fluorescence correlation spectroscopy relative to control2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID1635338Inhibition of SPT1 in human MCF7 cells assessed as suppression of 14C-serine incorporation into ceramide incubated for 2 hrs in presence of 4-HPR2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase.
AID386134Induction of GFP tagged PagsA-H2B expression in Aspergillus niger RD6.47 at 104.2 ug/mL by fluorescence microscopy2007The Journal of biological chemistry, Nov-09, Volume: 282, Issue:45
Survival in the presence of antifungals: genome-wide expression profiling of Aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph.
AID378118Antimicrobial activity against Bacillus cereus by disk diffusion assay2005Journal of natural products, Jan, Volume: 68, Issue:1
Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1392243Growth inhibition of human PL21 cells after 5 days by cell-titer-glo luminescent cell viability assay2018Bioorganic & medicinal chemistry, 05-15, Volume: 26, Issue:9
Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.
AID507277Inhibition of serine palmitoyltransferase in mouse DWT6.11 cells assessed as sphingomyelin level at 25 uM after 14 to 18 hrs by fluorescence correlation spectroscopy relative to control2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID386133Induction of GFP tagged PagsA expression in Aspergillus niger JvD1.1 at 104.2 ug/mL by fluorescence microscopy2007The Journal of biological chemistry, Nov-09, Volume: 282, Issue:45
Survival in the presence of antifungals: genome-wide expression profiling of Aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph.
AID507287Inhibition of serine palmitoyltransferase in human Jurkat JA16 cells assessed as lateral diffusion of the outer membrane leaflet-linked GFP-GRP1 PH nanodomain at 25 uM after 14 to 18 hrs by fluorescence correlation spectroscopy2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID185384Mean survival time of rats after skin allograft (intraperitoneal administration) at 0.1 mg/kg1996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols.
AID507274Inhibition of CD-28 triggered Akt phosphorylation in human Jurkat JA16 cells assessed as enzyme phosphorylation at Thr308 by immunoblotting analysis relative to control2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID507283Inhibition of serine palmitoyltransferase in human Jurkat JA16 cells assessed as lateral diffusion of the outer membrane leaflet-linked FL-PE nanodomain at 25 uM after 14 to 18 hrs by fluorescence correlation spectroscopy2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID507271Inhibition of CD-28 triggered Akt phosphorylation in mouse DWT6.11 cells assessed as enzyme phosphorylation at Thr308 by immunoblotting relative to control2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID512645Antiviral activity against Hepatitis C virus (isolate Con1) genotype 1b in human Huh-7/3-1 cells assessed as inhibition of HCV replication after 72 hrs by luciferase assay2005Nature chemical biology, Nov, Volume: 1, Issue:6
Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID507285Inhibition of serine palmitoyltransferase in human Jurkat JA16 cells assessed as lateral diffusion of the outer membrane leaflet-linked GFP-AKt PH nanodomain at 25 uM after 14 to 18 hrs by fluorescence correlation spectroscopy2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID512665Antiviral activity against Hepatitis C virus (isolate Con1) genotype 1b in human Huh-7/3-1 cells assessed as reduction in NS5B protein level in golgi-derived detergent-resistant membrane at 1 uM after 72 hrs by immunoblotting analysis2005Nature chemical biology, Nov, Volume: 1, Issue:6
Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.
AID378125Antimicrobial activity against Colletotrichum fragariae by disk diffusion assay2005Journal of natural products, Jan, Volume: 68, Issue:1
Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda.
AID1392238Growth inhibition of human HCC4006 cells assessed as inflection point after 5 days by cell-titer-glo luminescent cell viability assay2018Bioorganic & medicinal chemistry, 05-15, Volume: 26, Issue:9
Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.
AID596417Immunosuppressive activity in rat assessed as increase of skin graft survival time at 0.1 mg/kg2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
AID185385Mean survival time of rats after skin allograft (intraperitoneal administration) at 0.3 mg/kg1996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols.
AID507269Inhibition of serine palmitoyltransferase in african green monkey COS7 cells assessed as lateral diffusion of the outer leaflet-linked green fluorescent protein-GPI at 10 uM after 14 to 18 hrs by fluorescence correlation spectroscopy2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID507288Inhibition of serine palmitoyltransferase in mouse DWT6.11 cells assessed as lateral diffusion of the outer membrane leaflet-linked Lck(1-12)-GFP nanodomain at 25 uM after 14 to 18 hrs by fluorescence correlation spectroscopy2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID507278Inhibition of serine palmitoyltransferase in mouse DWT6.11 cells assessed as cholesterol level at 25 uM after 14 to 18 hrs by fluorescence correlation spectroscopy relative to control2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID1635337Inhibition of human SPT1 expressed in microsomes of HEK293 cells incubated for 1hr by LC/MS analysis2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase.
AID386136Antifungal activity against Aspergillus niger RD6.47 at 104.2 ug/mL by microtiter plate2007The Journal of biological chemistry, Nov-09, Volume: 282, Issue:45
Survival in the presence of antifungals: genome-wide expression profiling of Aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph.
AID378123Antimicrobial activity against Escherichia coli by disk diffusion assay2005Journal of natural products, Jan, Volume: 68, Issue:1
Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda.
AID378124Antimicrobial activity against Botrytis cinerea by disk diffusion assay2005Journal of natural products, Jan, Volume: 68, Issue:1
Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda.
AID507281Inhibition of serine palmitoyltransferase in african green monkey COS7 cells assessed as cholesterol level at 10 uM after 14 to 18 hrs by fluorescence correlation spectroscopy relative to control2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID507272Inhibition of CD-28 triggered Akt phosphorylation in mouse DWT6.11 cells assessed as enzyme phosphorylation at Ser473 by immunoblotting relative to control2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID507273Inhibition of CD-28 triggered Ras/MAPK in mouse DWT6.11 cells by immunoblotting analysis2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID378127Antimicrobial activity against Fusarium oxysporum by disk diffusion assay2005Journal of natural products, Jan, Volume: 68, Issue:1
Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda.
AID1392242Inhibition of SPT in human HCC4006 cells assessed as reduction in ceramide content after 24 hrs in presence of C16-ceramide-d31/C14-phosphatidylcholine-d72 by LC/MS analysis2018Bioorganic & medicinal chemistry, 05-15, Volume: 26, Issue:9
Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.
AID185389Mean survival time of rats after skin allograft (intraperitoneal administration) at 1 mg/kg; toxic - animals died1996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols.
AID378126Antimicrobial activity against Colletotrichum gloeosporioides by disk diffusion assay2005Journal of natural products, Jan, Volume: 68, Issue:1
Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda.
AID507275Inhibition of CD-28 triggered Akt phosphorylation in human Jurkat JA16 cells assessed as enzyme phosphorylation at Ser473 by immunoblotting analysis relative to control2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID386135Antifungal activity against Aspergillus niger JvD1.1 at 104.2 ug/mL by microtiter plate2007The Journal of biological chemistry, Nov-09, Volume: 282, Issue:45
Survival in the presence of antifungals: genome-wide expression profiling of Aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph.
AID378121Antimicrobial activity against Bacillus subtilis by disk diffusion assay2005Journal of natural products, Jan, Volume: 68, Issue:1
Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda.
AID132491Immunosuppressive activity on mouse allogenic MLR in vitro1996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols.
AID596405Toxicity in ip dosed F344 rat lateral thorax transplanted with dorsal skin of LEW rat assessed as concentration required for cause death2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
AID596404Immunosuppressive activity in BALB/c/C57BL/6 mouse T cells assessed as inhibition of alloantigen-induced cell proliferation after 96 hrs by measuring [3H]thymidine uptake by mixed lymphocyte reaction assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
AID507265Inhibition of serine palmitoyltransferase in human Jurkat JA16 cells assessed as sphingomyelin level at 25 uM after 14 to 18 hrs by fluorescence correlation spectroscopy relative to control2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID596408Inhibition of serine palmitoyltransferase in mouse spleen cells2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
AID507267Inhibition of serine palmitoyltransferase in african green monkey COS7 cells assessed as sphingomyelin level at 10 uM after 14 to 18 hrs by fluorescence correlation spectroscopy relative to control2008Nature chemical biology, Sep, Volume: 4, Issue:9
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.
AID1392237Inhibition of human SPT2 transfected in Freestyle293 cells using L-serine and palmitoyl-CoA as substrate preincubated for 60 mins followed by substrate addition measured after 15 mins by mass spectrometric analysis2018Bioorganic & medicinal chemistry, 05-15, Volume: 26, Issue:9
Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1345986Human serine palmitoyltransferase long chain base subunit 3 (Serine palmitoyltransferase)1995Biochemical and biophysical research communications, Jun-15, Volume: 211, Issue:2
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.
AID1345916Human serine palmitoyltransferase long chain base subunit 2 (Serine palmitoyltransferase)1995Biochemical and biophysical research communications, Jun-15, Volume: 211, Issue:2
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.
AID1345921Mouse serine palmitoyltransferase long chain base subunit 1 (Serine palmitoyltransferase)1995Biochemical and biophysical research communications, Jun-15, Volume: 211, Issue:2
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (265)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (1.51)18.7374
1990's17 (6.42)18.2507
2000's81 (30.57)29.6817
2010's130 (49.06)24.3611
2020's33 (12.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.81 (24.57)
Research Supply Index5.59 (2.92)
Research Growth Index5.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.37%)5.53%
Reviews15 (5.62%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other251 (94.01%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]